Clinical study of the effect of oral ulcer protective agent on the prevention and treatment of radioactive oral mucositis in nasopharyngeal carcinoma and serum inflammatory factors
Department of Radiotherapy,Hainan Provincial People′s Hospital,Haikou 570311,China (Huang G,Li ZJ,Kong FZ,Lin SM);Department of stomatology,First Affiliated Hospital of Hainan Medical College,Haikou 570102,China (Fu QY)
Abstract： Objective To evaluate the clinical efficacy of oral ulcer protective agent in the prevention and treatment of oral mucositis in nasopharyngeal carcinoma (NPC) radiotherapy and its effect upon serum inflammatory factors. Methods A total of 90 patients diagnosed with nasopharyngeal carcinoma presenting with grade I oral mucositis caused by radiotherapy in our hospital were selected and randomly divided into two groups. In the experimental group, oral ulcer protective agent was given, and Kangfuxin gargle was administered in the control group. The incidence time and degree of radioactive oral mucositis, visual analogue scale (VAS) pain score, serum levels of CRP, TGF-β1, IL-6 and T lymphocyte subsets were statistically compared between two groups by independent-sample t-test. Results At 4 and 6 weeks after corresponding treatment, the incidence of grade Ⅱ and Ⅲ oral mucositis in the experimental group was significantly lower than that in the control group (P=0.018,0.021,0.027,0.014)). In the experimental group, the incidence of moderate and severe pain assessed by VAS was significantly lower compared with that in the control group (P=0.019,0.025);After corresponding treatment, the CRP levels in both groups were down-regulated and the CRP level in the experimental group was considerably lower than that in the control group (P=0.013). The levels of TGF-β1 and IL-6 in the control group were significantly increased (P=0.015、0.021), whereas dramatically declined in the experimental group (P=0.012,0.019). CD3(+),CD4(+),CD8(+) and CD4(+)/CD8(+) were remarkably elevated in two groups, and more significant increase was observed in the experimental group (P=0.024,0.036,0.029,0.017). Conclusions Oral ulcer protective agent can effectively inhibit the progression of oral mucosal injury, shorten the healing time and relieve the pain of oral mucosal injury in patients with NPC., which is worthy of clinical application.
Huang Guang,Li Zhaojun,Kong Fanzhong et al. Clinical study of the effect of oral ulcer protective agent on the prevention and treatment of radioactive oral mucositis in nasopharyngeal carcinoma and serum inflammatory factors[J]. Chinese Journal of Radiation Oncology, 2018, 27(4): 360-364.
[1] Zhang L,Huang Y,Hong S,et al. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma:a multicentre,randomised,open-label,phase 3 trial[J].Lancet,2016,388(10054):1883-1892.DOI:10.1016/S0140-6736(16)31388-5. [2] Kong M,Hwang DS,Yoon SW,et al. The effect of clove-based herbal mouthwash on radiation-induced oral mucositis in patients with head and neck cancer:a single-blind randomized preliminary study[J].Oncol Targets Ther,2016,22(9):4533-4538.DOI:10.2147/OTT.S108769. [3] Dong F,Li Q,Wu J,et al. Carotid blowout syndrome after nasopharyngeal carcinoma radiotherapy:successful treatment by internal carotid artery occlusion after stent implantation failure[J].Springerplus,2016,5(1):1553.DOI:10.1186/s40064-016-3209-y. [4] Wong KH,Kuciejewska A,Sharabiani MT,et al. A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer[J].Radiother Oncol,2017,122(2):207-211.DOI:10.1016/j.radonc.2016.06.015. [5] Saikia A,Raphael V,Shunyu NB,et al. Analysis of Epstein Barr Virus Encoded RNA Expression in Nasopharyngeal Carcinoma in North-Eastern India:A Chromogenic in Situ Hybridization Based Study[J].Iran J Otorhinolaryngol,2016,28(87):267-274. [6] 龚芸,张丽,冯泽会,等.口炎清颗粒防治鼻咽癌患者放射性口腔炎的疗效观察[J].华西口腔医学杂志,2016,34(1):37-40. DOI:10.7518/hxkq.2016.01.008. Yun G,Li Z,Zehui F,et al. Effect of Kou Yan Qing Ke Li on the prevention and treatment of radiation-induced oral mucositis in patients with nasopharyngeal carcinoma[J]. West Chin J Stomatol,2016,34(1):37-40. DOI:10.7518/hxkq.2016.01.008. [7] Ouyang PY,Bi ZF,Zhang LN,et al,Outcomes of induction chemotherapy plus intensity-modulated radiotherapy (IMRT) versus IMRT plus concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma:a propensity matched study[J].Transl Oncol,2016,9(4):329-335.DOI:10.1016/j.tranon.2016.06.003. [8] Abo Enin HA,El Nabarawy NA,Elmonem RA.Treatment of radiation-induced oral mucositis using a novel accepted taste of prolonged release mucoadhesive bi-medicated double-layer buccal films[J].AAPS Pharm Sci Tech,2017,18(2):563-575.DOI:10.1208/s12249-016-0533-z. [9] 邱慧芝,莫浩元,钟宗良,等.鼻咽癌中国2008分期和UICC2002及2009分期临床应用的评价[J].中华肿瘤防治杂志,2011,18(18):1470-1474.DOI:10.16073/j.cnki.cjcpt.2011.18.015. Qiu HZ,Mo HY,Zhong ZLet al. Evaluation of clinical application of 2008 stage and UICC2002 and 2009 stages of nasopharyngeal carcinoma in China[J].Chin J Cancer Prevent Cont,2011,18(18):1470-1474.DOI:10.16073/j.cnki.cjcpt.2011.18.015. [10] Moslemi D,Nokhandani AM,Otaghsaraei MT,et al. Management of chemo/radiation-induced oral mucositis in patients with head and neck cancer:a review of the current literature[J].Radiother Oncol,2016,120(1):13-20.DOI:10.1016/j.radonc.2016.04.001. [11] Wu YT,Yen SL,Li CF,et al. Overexpression of transient receptor protein cation channel subfamily a member 1,confers an independent prognostic indicator in nasopharyngeal carcinoma[J].J Cancer,2016,7(10):1181-1188.DOI:10.7150/jca.15326. [12] Co JL,Mejia MB,Que JC,et al. Effectiveness of honey on radiation-induced oral mucositis,time to mucositis,weight loss,and treatment interruptions among patients with head and neck malignancies:A meta-analysis and systematic review of literature[J].Head Neck,2016,38(7):1119-1128.DOI:10.1002/hed.24431. [13] Luo Y,Feng M,Fan Z,et al. Effect of Kangfuxin solution on chemo/radiotherapy-induced mucositis in nasopharyngeal carcinoma patients:a multicenter,prospective randomized phase Ⅲ clinical study[J].Evid Based Complement Alternat Med,2016,2016:8692343.DOI:10.1155/2016/8692343. [14] Kataoka T,Kiyota N,Shimada T,et al. Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancer[J].Auris Nasus Larynx,2016,43(6):677-684.DOI:10.1016/j.anl.2016.02.012. [15] Gu J,Yin L,Wu J,et al. Cetuximab and cisplatin show different combination effect in nasopharyngeal carcinoma cells lines via inactivation of EGFR/AKT Signaling Pathway[J].Biochem Res Int,2016,2016:7016907.DOI:10.1155/2016/7016907. [16] Xu T,Liu Y,Dou S,et al. Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma:Results of a randomized phase Ⅱ study[J].Oral Oncol,2015,51(9):875-879.DOI:10.1016/j.oraloncology.2015.06.008. [17] Du L,Zhang XX,Feng LC,et al. Treatment of nasopharyngeal carcinoma using simultaneous modulated accelerated radiation therapy via helical tomotherapy:a phase Ⅱ study[J].Radiol Oncol,2016,50(2):218-825.DOI:10.1515/raon-2016-0001. [18] Moura JF,Mota JM,Leite CA,et al. A novel model of megavoltage radiation-induced oral mucositis in hamsters:role of inflammatory cytokines and nitric oxide[J].Int J Radiat Biol,2015,91(6):500-509.DOI:10.3109/09553002.2015.1021964. [19] 兰桂萍,黄波,司勇锋,等.内镜经鼻入路处理鼻咽癌放疗后颅底骨坏死临床体会[J].中华耳鼻咽喉头颈外科杂志,2016,51(5):367-371.DOI:10.3760/cma.j.issn.1673-0860.2016.05.010. Lan G,Huang B,Si Y,et al. The clinical experience of transnasal endoscopic approach for skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma[J].Chin J Otorhinolaryngol Head Neck Surg,2016,51(5):367-371.DOI:10.3760/cma.j.issn.1673-0860.2016.05.010. [20] Gautam AP,Fernandes DJ,Vidyasagar MS,et al. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial[J].J Photochem Photobiol B,2015,144:51-56.DOI:10.1016/j.jphotobiol.2015.01.011. [21] Zhang P,Hong H,Sun X,et al. MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal carcinoma cells[J].Am J Cancer Res,2016,6(2):141-156. [22] Bonfili P,Gravina GL,Marampon F,et al. Oral platelet gel supernatant plus supportive medical treatment versus supportive medical treatment in the management of radiation-induced oral mucositis:a matched explorative active control trial by propensity analysis[J].Am J Clin Oncol,2017,40(4):336-341.DOI:10.1097/COC.0000000000000177. [23] Chen SC,Lai YH,Huang BS,et al. Changes and predictors of radiation-induced oral mucositis in patients with oral cavity cancer during active treatment[J].Eur J Oncol Nurs,2015,19(3):214-219.DOI:10.1016/j.ejon.2014.12.001.
2018, Vol. 27 
